Vincent de Caprio
Directeur/Membre du Conseil chez New Jersey Institute of Technology
Profil
Vincent de Caprio was President and Chief Executive Officer of Vyteris Holdings, Inc. He joined Vyteris Holdings, Inc. in 2000.
He is a Fellow of the American Institute of Medical and Biological Engineering.
He is a Trustee of New Jersey Institute of Technology.
He received a BSEE degree from the Newark College of Engineering in 1972, an MS degree in 1975 from Polytechnic University and a PhD in 1977 from Polytechnic University.
Postes actifs de Vincent de Caprio
Sociétés | Poste | Début |
---|---|---|
New Jersey Institute of Technology | Directeur/Membre du Conseil | - |
Anciens postes connus de Vincent de Caprio
Sociétés | Poste | Fin |
---|---|---|
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | President | 31/12/2005 |
Treasure Mountain Holdings, Inc. | President | 17/05/2005 |
Formation de Vincent de Caprio
New Jersey Institute of Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Treasure Mountain Holdings, Inc. | Producer Manufacturing |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
Polytechnic University | Consumer Services |